Parvo Virus, Papilloma And Polyoma Virus Flashcards
Parvovirus
Characteristics
Icosahedral capsid
SS DNA
Naked
Non envelopd
Parvovirus
Major capsid protein
Non structural protein requires for replication
Parvovirus
Replicates only during the
Stationary phase
Parvovirus
Requires helper virus
Adenovirus
Parvovirus
Causes infection in humans
B19 virus
Parvovirus
Classification
- Parvoviridae
2. Desoviridae
Parvovirus
Parvoviridae
Erthythrovirus
Bocavirus
Dependovirus
Parvovirus
Erthythrovirus
Parvovirus B19 type 1
Strain k71 type 2
Strain v9 type 3
Parvovirus
defective virus that is an adeno-associated virus
Dependovirus
Parvovirus
Infect the insects
Desoviridae
B19
Cellular receptor
Blood group B antigen
B19
Erythroblastosis in the bone marrow
Aplastic anemia
B19
Endothelial cells on the blood vessels
Rash
Parvovirus B19
Mode of transmission
Respiratory and oral secretions Blood transfusion Transplacental Human ar only natural reservoir No virus excretion in the urine
Parvovirus B19
Targets the
Immature cells in the erythroid lineage
Parvovirus B19
Major site of replication are in the
Bone marrow
Fetal liver
Some blood vessels
Parvovirus B19
Replication can cause
Death
Parvovirus B19
Syndromes involved
Erythema infectiosum/ 5th disease
Transient aplastic crisis
Pure red cell aplasia
Hydrops fetalis
Erythema infectiosum/ 5th disease
Including
Rosella rubella
Rubeolla
Varicella
Erythema infectiosum/ 5th disease
Occurs in
Early school age
Adults
Erythema infectiosum/ 5th disease
Ip
1-2 weeks
Erythema infectiosum/ 5th disease
Most probable site of viral shedding
Pharynx
Erythema infectiosum/ 5th disease
Contagious stage
Lytic stage
Erythema infectiosum/ 5th disease
Highest titter
Respiratory
Oral secretions
Erythema infectiosum/ 5th disease
Enters through the respiratory tract then spreads to _________ stopping of RBC production due to viral killing of erythroid series
Bone marrow - adult
Fetal liver - children
Erythema infectiosum/ 5th disease
Viremia
1 week after infection
Erythema infectiosum/ 5th disease
Pathogenesis
Respiratory tract Bone marrow Stop RBC Viremia Contagious stage Persist 5 days Present in nasal washes and gargle specimen
Erythema infectiosum/ 5th disease
2nd stage of illness
Immunologic stage Appearance of antibodies Resolution of disease Erythematous Rash and arthralgia
Appearance of B 19 virus specific
Anti IgM
Erythema infectiosum/ 5th disease
Generalized erythematous rash most prominent in the face
Cutaneous rash or slapped cheek
Erythema infectiosum/ 5th disease
Arthralgia
Hands and knees
Adult
Transient aplastic crisis
Occur in patient with
Chronic hemolytic anemia
After bone marrow transplantation
Transient aplastic crisis
Only in patients with hemolytic anemia
Abrupt cessation of RBC synthesis
Persistent infection and chronic anemia
Immunocompromised patient
Pure red cell aphasia
Fetus is affected
Result of severe fetal anemia, especially in 2nd trimester
Hydrops fetalis
Fetal death before 20th week of pregnancy
Hydrops fetalis
No congenital abnormalities because the blood is the one affected
Prevalent in children with acute wheezing
Often found in mixed infections with other viruses
Human Bocavirus respiratory infection
Human Bocavirus respiratory infection
Pathogenesis
Unknown
Human Bocavirus respiratory infection
MOT
Respiratory route
Also detect in stool and serum samples
Parvovirus diagnosis
Most sensitive, in situ hybridization of fixed tissues
PCR
Parvovirus diagnosis
Serology
B19 IgM antibody
Present 2-3 months after infection
Parvovirus treatment
5th disease
Symptomatic treatment
Parvovirus treatment
Transient aplastic crisis
Symptomatic
Blood transfusion
Parvovirus treatment
For immunocompromised and those with anemia
Immunoglobulin preparations containing antibodies
Parvovirus treatment
Vaccine
No vaccine available
Papovavirus
Old classification and does not exist
2 families
Papilloma virus
Polyomavirus
Capable of causing lytic, chronic, latent, and transforming infection depending on host cell
Papovavirus
Papovavirus
Morphology
Small
Icosahedral capsid
Non enveloped
DS DNA
Papovavirus
Encode proteins that promote
Cell growth
Lytic viral replications
Permissive cell type
Oncogenically transformed non permissive cell type
Papovavirus
Stimulate cell growth which facilitate replication of the viral genome
Codes for no structural protein
Early Genes ( E1-E7)
Papovavirus
example of early gene
BT1
BT2
BT3
Papovavirus
Viral attachment portein
Codes for structural protein
Late genes (L1 and L2)
Human Papilloma virus
Former member of the papoviridae
Human Papilloma virus
Characteristics
Double stranded circular CAN
Icosahedral
Naked
Human Papilloma virus
Oncogenic
E6 and E7 oncoproteins
Human Papilloma virus
Do not grow in
Cell cultures
Human Papilloma virus
Capsomeres form
Regular pointed star shaped head
Human Papilloma virus
Have defined tissue tropism
Epithelial cells of skin and mucous membrane
Human Papilloma virus
Result mutation and stimulation of nuclear factors to chromosomal aberration
E7 protein to p105RB (retinoblastoma)
Human Papilloma virus
Encode early 7 genes and late 2 genes
E6 protein to p53
Human Papilloma virus
100 types of papilloma virus that are grouped into
1-16
Human Papilloma virus
Lytic infections
Permissive cells
Human Papilloma virus
Abortive, latent, persistent or immortalizing infections that can transform the cell into cancer
Non-permissive cells
Human Papilloma virus
Important characteristics
Stimulate DNA synthesis
Tissue tropism
Significant cause of human cancer
Viral oncoproteins
Human Papilloma virus
Classifications
Alpha Beta Gamma Mupa Napa
Human Papilloma virus
HPV type of plantar warts
1
Benign
Human Papilloma virus
Type of common skin warts
2,4,27,57
Benign
Human Papilloma virus
Type of HPV cutaneous lesions
3,10,28,29,60,76,78
Low
Human Papilloma virus
Epidermodysplasia verruciformis
5 8 9 12 17 20 36 47
Mostly benign
Human Papilloma virus
Hand warts of butchers
7
Low
Human Papilloma virus
Anogenital warts
6,11,40,42-44,54,61,70,72,81
Low
Human Papilloma virus
Infect and replicate in the
Squamous epithelium (warts) Mucous membranes (papilloma virus)
Human Papilloma virus
Enlarged keratinocytes with haloes around shrunken nuclei
Koilocytes
Human Papilloma virus
Infection may regress spontaneously but
Recurrence is common
Human Papilloma virus
Important in the resolution of and control of the infection
Innate immunity and CMI
Human Papilloma virus
MOT
Direct contact- due to shedding
Minor skin abrasions
Sexual contact - anogenital warts
Human Papilloma virus
Mole and warts
Mole- smooth surfaces
Warts- rough
Human Papilloma virus
Skin warts
1-4
Human Papilloma virus
Laryngeal papilloma
6 and 11
Human Papilloma virus
Anogenital warts
6&11
Condylomata acuminata
Human Papilloma virus
Cervical, orophanyngeal and penile Ca
Worst type of warts
16 and 18
Human Papilloma virus
It takes 3-4 months before a wart can develop
Once you have a warts, faster spread
Epidermodysplasia verruciformis
Human Papilloma virus
Usually in the face and body
Flat warts
Human Papilloma virus
Domed shape warts
Hands and feet
Common warts
Human Papilloma virus
Skin tags
Cutaneous lesion
Human Papilloma virus
Usually malignant Sun exposure 30-40 Mixed type HPV Very rare autosomal recessive
Epidermidis plasma verruciformis
Human Papilloma virus
Laboratory diagnosis
Cytology
DNA molecular probe
PCR
Southern blot
Human Papilloma virus
Treatment
Used for common warts
Surgical excision
Human Papilloma virus
Treatment
For flat warts
Application of caustic agents
Electro cautery
Cryosurgery
Human Papilloma virus
Treatment
Drugs
Imiquimod
Topical idoxuridine
Systemic or intralesional alpha interferon
Cidofovir
Human Papilloma virus
Prevention
From HPV 6,11,16 and 18
Quadrivalent vaccine
Human Papilloma virus
Prevention
From type 16 and 18 for high risk patient
Bivalent
Human Papilloma virus
Vaccine given as early ____ before they become sexually active
11
Yung polyoma virus, wala pang BS
Kpag may time pa gawan, kung wala na, dun mo na lang aralin,
Smallest and simplest of all DNA viruses
Parvovirus